Shizume K
Endocrinol Jpn. 1978 Aug;25(4):377-9. doi: 10.1507/endocrj1954.25.377.
Among the 504 patients with Graves' disease in whom the author initiated antithyroid drug therapy between 1956 and 1968 are 14 to whom the administration of antithyroid drug has been continued for 8 to 21 years because of recurrence shortly after the discontinuation of drugs. During these periods, no side effects were observed and three patients went into complete remission after 8, 9 and 20 years of antithyroid drug administration, respectively. It is suggested therefore that the long term administration of antithryoid drugs can be a useful treatment for intractable cases.
在1956年至1968年间作者开始使用抗甲状腺药物治疗的504例格雷夫斯病患者中,有14例因停药后不久复发而持续服用抗甲状腺药物8至21年。在此期间,未观察到副作用,3例患者分别在服用抗甲状腺药物8年、9年和20年后完全缓解。因此,提示长期服用抗甲状腺药物可能是治疗难治性病例的一种有效方法。